We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.60
Bid: 1,202.40
Ask: 1,202.80
Change: 0.00 (0.00%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,201.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LIVE MARKETS-Because Tina

* European stocks up 0.6%* UK blue chips underperform main European bourses* EU talks in focus* Italy's UBI surges after Intesa raises bid by 18% Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks...

20 Jul 20 14:22

LONDON MARKET MIDDAY: Stocks Down As EU Recovery Fund Talks Continue

LONDON MARKET MIDDAY: Stocks Down As EU Recovery Fund Talks Continue

20 Jul 20 12:16

LIVE MARKETS-Time to give UK PLC a break

* European stocks slightly up* EU talks in focus* Italy's UBI surges after Intesa raises bid by 18% Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice ...

20 Jul 20 12:15

LIVE MARKETS-Is big cash from central banks prolonging the crisis?

* European stocks flat* EU talks in focus* Italy's UBI surges after Intesa raises bid by 18% Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (...

20 Jul 20 11:25

LONDON MARKET OPEN: EU Summit Continues; AstraZeneca Vaccine In Focus

LONDON MARKET OPEN: EU Summit Continues; AstraZeneca Vaccine In Focus

20 Jul 20 08:55

LIVE MARKETS-Opening snapshot: Risk-off on "Mission impossible"

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in Lon...

20 Jul 20 08:40

Glaxo To Invest In Germany's CureVac As Partner To Develop Vaccines

Glaxo To Invest In Germany's CureVac As Partner To Develop Vaccines

20 Jul 20 08:33

LIVE MARKETS-On the radar: Julius Baer, Philips, M&S, homebuilders

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in Lon...

20 Jul 20 07:53

UPDATE 2-GSK buys 10% of CureVac in vaccine tech deal

* GSK invests 130 mln stg, CureVac could get further 606 mln stg* CureVac's mRNA experience complements GSK's expertise - exec* CureVac IPO expected in the autumn (Rewrites, adds source, CureVac comment on IPO)By Pushkala Aripaka and Arno Schuetze...

20 Jul 20 07:29

GSK takes 10% stake in CureVac for £130m in collaboration deal

(Sharecast News) - GlaxoSmithKline said it would invest £130m to take a 10% stake in Germany's CureVac and collaborate to develop up to five mRNA-based vaccines and antibodies to fight infectious diseases.

20 Jul 20 06:56

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.

15 Jul 20 12:24

UPDATE 2-UK stocks end higher on healthcare boost, growing vaccine hopes

* Potential Oxford/AstraZeneca vaccine news helps gains* U.S. health panel votes in favour of GSK's blood cancer drug* HSBC, Standard Chartered lag on Hong Kong tensions* ASOS jumps, Burberry slumps on mixed earnings updates (Updates to close)By Sh...

15 Jul 20 09:25

GlaxoSmithKline myeloma treatment gets nod from FDA committee

(Sharecast News) - GlaxoSmithKline announced on Wednesday that the oncologic drugs advisory committee of the US Food and Drug Administration (FDA) has voted in favour of "the demonstrated benefit" of monotherapy treatment with 'belantamab mafodotin'.

15 Jul 20 07:30

GSK's Belantamab Gets US Committee Nod But Awaiting FDA Green Light

GSK's Belantamab Gets US Committee Nod But Awaiting FDA Green Light

15 Jul 20 06:31

Morgan Stanley sees cycle turning higher for 'value' stocks

(Sharecast News) - Equity strategists at Morgan Stanley sounded a positive note on so-called 'value' stocks, arguing that the economic cycle was shifting into a 'recovery regime' - but there was catch.

13 Jul 20 13:55

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.